Acorda TherapeuticsACORQ
13F holders, Q2 2024 (June 30)2holders −15
0new positions
16sold out
$0.24avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Acorda Therapeutics Inc. (ACORQ) in their 13F filings, down 15 from Q1 2024. 0 opened new positions and 16 sold out. The largest holders were Acadian Asset Management LLC ($8K) and Osaic Holdings, Inc. ($0).
- Company
- Acorda Therapeutics Inc.
- CUSIP
- 00484M700
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 16 | $1.7M |
All 13F filers, Q1 2024 → Q2 2024: 132,737 shares sold, net −132,737 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Acadian Asset Management LLC | 0.00% | No change | 33,691 | $8K |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is ACORQ's weight in each manager's 13F, not the share of Acorda Therapeutics Inc. the manager owns.